INFORMED.
LIVE

TAKE LIMITED

BSE: TAKE532890ISIN INE142I01023
  • Healthcare
  • Healthcare Research, Analytics & Technology
  • BSE Healthcare

Share price

₹11.47+0.54 (+4.94%)
as of 4 Nov 2026
TAKE LIMITED share price, 4 Nov 2025 to 4 Nov 2026: ₹23.95 to ₹11.47 (-52.1%). Low ₹10.34, high ₹49.88. Volume shown below the price.

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high
₹49.90
52W low
₹9.83
Off 52W high
-77.01%
1M return
-4.97%
3M return
-48.08%
6M return
-68.52%
1Y return
-52.11%
20D avg volume
62,534
50 DMA
₹14.03
200 DMA
₹29.09

Key ratios Consolidated

Market cap
₹169.68 Cr
Current price
₹11.47
52W high / low
₹49.90 / ₹9.83
Face value
₹1.00
P/E
0.00
P/B
5.47
EPS (TTM)
₹0.00
Book value / share
₹2.10
ROE
—
ROCE
15.40%
Operating margin
—
Net margin
—
Debt / equity
0.00
Net debt
₹-0.26 Cr
Interest cover
13.63
Dividend yield
—
Dividend / share (TTM)
—
Payout
—
Cash conversion cycle
-7.2 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24
Income statement
30.3754.190.000.000.000.000.000.000.00—
1.335.181.460.000.041.708.520.000.00—
31.7059.371.460.000.041.708.520.000.00—
30.6455.010.350.470.951.393.631.742.73—
0.000.000.000.000.000.00————
30.2754.200.000.000.000.00————
0.070.010.140.140.140.140.410.240.31—
0.000.000.000.170.170.240.730.500.49—
0.000.000.000.000.000.010.010.010.01—
0.300.790.210.160.641.002.480.981.92—
1.064.361.11-0.47-0.910.304.89-1.74-2.73—
0.000.000.000.000.000.000.000.000.00—
1.064.361.11-0.47-0.910.304.89-1.74-2.73—
0.000.000.000.160.000.000.000.060.06—
1.064.361.116.29-0.91-4.8847.68-1.58-3.75—
0.070.290.070.43-0.06-0.330.33-0.11-0.19—
Key metrics
1.064.361.11-0.30-0.740.555.63-1.23-2.23—
3.50%8.00%————————
3.50%8.00%————————
—14.10%—-1.20%—2.60%————
216.50%189.30%-97.70%498.10%75.70%—————
MetricTTMFY26FY25FY24
Income statement
84.5654.190.00—
7.976.6910.22—
92.5360.8710.22—
86.4756.469.48—
0.000.000.00—
84.4754.200.00—
0.360.421.09—
0.170.351.96—
0.000.010.04—
1.461.486.38—
6.064.420.74—
0.000.000.00—
6.064.420.74—
0.160.160.00—
12.8210.8537.47—
0.860.742.56—
Key metrics
6.234.782.74—
7.37%8.80%——
15.16%20.00%——
—15.40%13.20%—
-68.20%-71.00%——
—-4.13-16.37—
—-0.38-0.44—
—0.000.00—
—-0.26-3.37—
—-7.2——
Balance sheet
—36.2436.48—
—23.7723.55—
—0.263.37—
—0.220.00—
—0.000.00—
—4.917.86—
—0.000.00—
—1.291.49—
—5.2415.95—
—0.000.00—
—0.000.00—
—0.000.00—
—31.0020.53—
Cash flow
—-4.13-16.37—
—1.7422.21—
—-0.72-3.24—
—0.000.00—
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24
Income statement
11.970.000.000.000.000.00——0.90—
1.335.181.46-0.040.0110.872.910.350.45—
13.305.181.46-0.040.0110.872.910.350.45—
12.330.790.350.432.170.910.991.060.78—
0.000.000.000.000.000.00————
11.970.000.000.000.000.00————
0.070.010.140.140.140.140.380.240.31—
0.000.000.000.150.150.200.210.160.16—
0.000.000.000.000.000.010.010.010.01—
0.280.780.210.151.890.560.390.650.30—
0.974.391.11-0.47-2.179.961.92-1.41-0.34—
0.000.000.000.000.000.00————
0.974.391.11-0.47-2.179.961.92-1.41-0.34—
0.000.000.000.160.000.00—0.060.06—
0.974.391.11-0.62-2.174.780.94-27.57-47.88—
0.070.300.08-0.04-0.150.670.13-0.09-0.03—
Key metrics
0.974.391.11-0.32-2.0210.172.14-1.24-0.17—
8.10%—————73.50%-354.30%-18.90%—
8.10%—————32.30%-7,877.10%-5,320.00%—
—15.40%—-1.40%—39.40%————
——-100.00%-100.00%-100.00%—————
144.70%-8.20%18.10%97.80%95.50%—————
MetricTTMFY26FY25FY24
Income statement
11.970.000.90—
7.936.6212.98—
19.906.6213.88—
13.903.753.75—
0.000.000.00—
11.970.000.00—
0.360.421.06—
0.150.290.74—
0.000.010.04—
1.423.021.90—
6.002.8710.13—
0.000.000.00—
6.002.8710.13—
0.160.160.00—
5.852.72-69.74—
0.410.18-4.72—
Key metrics
6.153.1710.91—
51.38%—1,212.20%—
48.87%—-7,748.90%—
—11.10%42.20%—
—-100.00%——
—103.90%——
—-0.62-19.51—
—-0.230.28—
—0.000.00—
—-0.25-3.16—
——-85.2—
Balance sheet
—30.0531.66—
—21.0422.45—
—0.253.16—
—0.000.00—
—0.000.00—
—4.915.36—
—0.000.00—
—0.450.21—
—1.565.90—
—0.000.00—
—0.000.00—
—0.000.00—
—28.4925.77—
Cash flow
—-0.62-19.51—
—-2.0022.21—
—-0.29-0.04—
—0.000.00—

Compounded growth

Standalone

Sales CAGR 3Y
—
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
-15.35%
Profit YoY (TTM)
+124.35%

Consolidated

Sales CAGR 3Y
—
Sales CAGR 5Y
—
Profit CAGR 3Y
—
Profit CAGR 5Y
—
Sales YoY (TTM)
—
Profit YoY (TTM)
-68.20%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding
0.00%
QuarterSeptember 2026June 2026
Promoter %0.00%0.00%
HolderTypeHoldingPreviousChange
AKARSHIKA TRADERS LLPPublic10.87%——
WHAMIA TRADERS LLPPublic7.02%7.11%-0.09%
VAISHALI COMMOSALES LLPPublic5.77%5.27%+0.50%
MOONLIGHT MULTITRADE LLPPublic5.38%5.59%-0.21%
RUKHMANI GARMENTS LLPPublic5.31%5.65%-0.34%
ZUBER TRADING LLPPublic5.04%5.11%-0.07%
SARVAGAY TEXTILEPublic4.82%4.81%+0.01%
AVANCE VENTURES PRIVATE LIMITEDPublic3.83%5.48%-1.65%
EMPOWER TRADEX PRIVATE LIMITEDPublic3.35%2.74%+0.61%
NIKHILESH TRADERS LLPPublic3.15%3.11%+0.04%
ALIA COMMOSALES LLPPublic2.71%——
SADBHAV MINERALS PRIVATE LIMITEDPublic2.32%2.32%0.00%
THE NORTH CONSULTINGPublic1.16%1.16%0.00%
Take Solutions Pte LimitedPromoter0.00%0.00%0.00%
Aakanksha Management Consultancy and Holdings Private LimitedPromoter Group0.00%0.00%0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

CompanyMkt cap (₹ Cr)Price (₹)P/EROCESales YoYProfit YoY1Y return
Syngene International Limited16,841417.2090.498.40%-5.99% TTM-60.25% TTM-35.44%
Indegene Limited14,870617.0536.1715.40%+35.84% TTM-7.78% TTM+14.61%
Suven Life Sciences Ltd.7,803276.15-22.14-46.50%+17.29% TTM-91.30% TTM+40.18%
Vimta Labs Ltd.2,230498.80——+4.90% TTM+48.48% TTM-24.58%
NOVELIX PHARMACEUTICALS LIMITED S19468.0053.546.70%+179.89% TTM+535.09% TTM+29.52%
Bilcare Ltd.18377.6916.519.20%+11.44% TTM+125.02% TTM-25.62%
TAKE LIMITED S17011.4729.0011.10%-15.35% TTM+124.35% TTM-52.11%
Jeevan Scientific Technology Limited16481.7032.024.80%+66.05% TTM+222.49% TTM+30.72%
GlobalSpace Technologies Limited9928.8429.215.00%+37.21% TTM+398.53% TTM+63.12%
Adeshwar Meditex Limited S2718.8021.366.00%——+1.62%
Vanta Bioscience Limited1420.39—1.50%——-5.86%

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results